Comparison of Chitosan, Ankaferd and Tranexamic Acid in Dental Extraction in Liver Pre-Transplant Children
NCT ID: NCT06457360
Last Updated: 2024-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
39 participants
INTERVENTIONAL
2023-11-15
2024-05-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To assess the hemostatic effect of chitosan-based dressing, Ankaferd and Tranexamic acid after extraction in children with end stage liver diseases where the:
• Primary objective: is to evaluate which of the previous materials will be the most effective as a hemostatic agent
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of a Carvacrol-loaded Absorbable Gelatin Sponge Used As a Palatal Dressing Following Free Gingival Graft Harvesting: a Randomized Clinical Study
NCT06806566
Improving Healing in Children After Tooth Extraction Using Laser Therapy or Hyaluronic Acid
NCT07205640
Evaluation of Pulpotomy Success of Different Methods
NCT06403306
Clinical and Radiographic Outcomes of PRF, Chitosan, and Blood Clot in Regenerative Endodontics of Molars
NCT07119619
Clinical and Radiographic Success Following Regenerative Pulpotomy Using Chitosan Hydrogel Versus Platelet Rich Fibrin in Mature Mandibular Molars
NCT06828978
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group 1 sterile gauze with chitosan
Chitosan-based dressing gauze after extraction in patients with end stage liver disease
Chitosan
Application of sterile gauze after extraction for hemostasis
group 2 sterile gauze with ankaferd blood stopper
ankaferd blood stopper dressing gauze after extraction in patients with end stage liver disease
Ankaferd Blood Stopper
Application of sterile gauze after extraction for hemostasis
group 3 sterile gauze with tranexamic acid
tranexamic acid dressing gauze after extraction in patients with end stage liver disease
tranexamic acid
Application of sterile gauze after extraction for hemostasis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
tranexamic acid
Application of sterile gauze after extraction for hemostasis
Ankaferd Blood Stopper
Application of sterile gauze after extraction for hemostasis
Chitosan
Application of sterile gauze after extraction for hemostasis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients aged between 4 and 9 years old
3. Patients having international normalized ratio (INR) values ≤ 4 (i.e. 1-4)
Exclusion Criteria
2. Patients having genetic bleeding disorders
3. Patients with renal diseases
4 Years
9 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
British University In Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
noha S Kabil
Role: PRINCIPAL_INVESTIGATOR
British University In Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
British University in Egypt
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PED 20-2D
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.